BGLC
BioNexus Gene Lab Corp.
There isn't enough reported data to score BGLC yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
BGLC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Strong |
BGLC's balance sheet is currently strong, but its revenue, profitability and cash flow are weak.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
BGLC PE Valuation
BGLC has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
BGLC Forward outlook
There aren't enough analyst estimates for BGLC to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
BGLC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2022 | -$0.07 | -105% |
| Q2 2022 | -$0.02 | -101% |
| Q1 2022 | $0.07 | -95% |
| Q4 2021 | $0.06 | -96% |
| Q3 2021 | $1.44 | +586% |
| Q2 2021 | $1.44 | +586% |
| Q1 2021 | $1.44 | +1340% |
| Q4 2020 | $1.44 | +$1.44 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 1,943% for BGLC versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
BGLC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $76.2K | -97% |
| Q1 2026 | $22.8K | -99% |
| Q4 2025 | $483.8K | -81% |
| Q3 2025 | $2.5M | -3.3% |
| Q2 2025 | $2.3M | +14% |
| Q1 2025 | $2.1M | -10% |
| Q4 2024 | $2.5M | +11% |
| Q3 2024 | $2.6M | +3% |
BGLC's revenue has slid since its 2020 peak: $76,156 last quarter, down 97% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -371% | -344 points |
| Q1 2026 | -2366% | -2337 points |
| Q4 2025 | -214% | -197 points |
| Q3 2025 | -28% | +23 points |
| Q2 2025 | -27% | -40 points |
| Q1 2025 | -29% | -26 points |
| Q4 2024 | -16% | -28 points |
| Q3 2024 | -51% | +48 points |
BGLC's operating margin was −371% last quarter, down 344 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over BGLC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over BGLC on profitability, with a higher operating margin.
BGLC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$422.7K | +$336.6K |
| Q1 2026 | -$148K | +$685.1K |
| Q4 2025 | $960.1K | +$1M |
| Q2 2025 | -$759.4K | -$88.8K |
| Q1 2025 | -$833.1K | -$798.7K |
| Q4 2024 | -$73.8K | +$39.7K |
| Q2 2024 | -$670.5K | -$634.1K |
| Q1 2024 | -$34.4K | +$84K |
BGLC has burned cash in most quarters: −$853,600 over the past year, against −$2M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over BGLC on cash generation, producing positive trailing cash flow while its opponent burns cash.
BGLC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +35% | +621K shares |
| 3 years | +37% | +647K shares |
| 5 years | +69% | +990K shares |
| Available history | +294% | +1.8M shares |
BGLC has 2M diluted shares, up 35% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over BGLC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
BGLC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -3.9x | Net Cash |
| Q2 2022 | -0.9x | Net Cash |
| Q1 2022 | -2.2x | Net Cash |
| Q4 2021 | -1.9x | Net Cash |
| Q3 2021 | -0.7x | Net Cash |
| Q2 2021 | -0.8x | Net Cash |
| Q1 2021 | -1.4x | Net Cash |
| Q4 2020 | -2.0x | Net Cash |
BGLC has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
BGLC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.0 | Oversold |
| Stochastic | 4.3 | Oversold |
BGLC's weekly RSI is 30 (oversold) and its Stochastic is 4 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
BGLC PE vs Healthcare Sector
| Metric | BGLC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BGLC has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
BGLC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.12 | 19% below |
| 20 week MA | $1.42 | 36% below |
| 50 week MA | $2.19 | 58% below |
| 100 week MA | $3.15 | 71% below |
| 200 week MA | $12.5 | 93% below |
BGLC is in a downtrend: it's below all five of its weekly moving averages, and 93% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over BGLC on trend strength, trading above more of its moving averages.
BGLC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $264.0 | $228.0 | -14% |
| 2022 | $228.0 | $114.0 | -50% |
| 2023 | $114.0 | $5.30 | -95% |
| 2024 | $5.30 | $2.67 | -50% |
| 2025 | $2.67 | $4.14 | +55% |
| 2026 YTD | $4.14 | $0.91 | -78% |
BGLC has finished lower in four of the last five years. It's down 78% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over BGLC on returns for 2026, with the stronger performance.